Authors
Bleddyn Jones
Published in
Frontiers in oncology. Volume 16. Pages 1951206. Epub Oct 28, 2026.
Abstract
To study tumour responses and the changes in radiobiological parameters which may better inform decision making applied to overall time issues and treatment delays in a variety of histological tumour types during radiotherapy.
Classical cell kinetic equations and radiobiological principles have been combined to study changes in effective doubling time (Teff ) and repopulation dose equivalents (Krepop) during radiotherapy in a model which includes a non-proliferating radioresistant hypoxic fraction, reoxygenation, and a reducing cell loss factor (φ) governed by the tumour volume doubling time (TD ), such that longer TD times will have longer apparent onset times of AR (accelerated repopulation).
The model found shortening of Teff at a time commensurate with the onset of accelerated repopulation in well-defined histological tumour types with their typical cell kinetic characteristics, along with diminishing extents of tumour hypoxia with time. The Krepop values show a steady increase during treatment and become closer to the constant Krepop values normally used in treatment interruption assessments for each histological class. Tumour classes with lower initial φ values show a greater persistence of hypoxia; those with very long initial TD values do not develop accelerated repopulation during or closely after radiotherapy, their Krepop values remaining low.
The current use of constant Krepop values only after critical AR onset time durations may be sub-optimal in treatment interruption compensations since Krepop probably varies continuously with time due to progressive shortening of Teff . For shorter schedules, use of high K values (as used for longer schedules) could result in compensatory overdosage; lower compensatory doses obtained by using lower Krepop values should be preferred with no lag time to AR onset. Very prolonged interruptions probably require the highest Krepop values appropriate for the time at which compensation occurs.
PMID:
43016451
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0